We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2327:TWSEYageo Corporation Analysis

Data as of 2026-05-27 - not real-time

NT$701.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Yageo shares are trading near their 52‑week high with a bullish technical backdrop: the short‑term moving average sits above the medium‑term average, the MACD line is comfortably above its signal, and the histogram remains positive, underscoring strong momentum. However, the RSI has surged into overbought territory, volatility is elevated and the beta is above the market, suggesting a heightened risk of a near‑term pullback. Fundamentally, the company delivers solid top‑line growth and healthy operating margins, backed by robust cash generation and a moderate dividend payout. Yet the price‑to‑earnings multiple is markedly higher than the industry average and the discounted cash‑flow model points to a fair value well below the current market price, indicating limited upside. Leverage is a concern, with debt levels far exceeding equity, and the dividend yield is modest, raising questions about long‑term sustainability. In this context, the stock appears overvalued despite its growth credentials, and investors should weigh the strong momentum against the valuation gap and balance‑sheet risks.
Given the mixed signals, a cautious stance is advisable. Short‑term traders may consider exiting or holding off on new purchases due to the overbought conditions and constrained upside. Medium‑term investors might adopt a wait‑and‑see approach, monitoring earnings trends and any shifts in valuation metrics. Long‑term holders could find merit in the company’s market position and cash‑flow strength, but should remain vigilant about valuation compression and debt exposure.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • DCF fair value far below market price
  • Elevated volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth and cash flow
  • High valuation multiples
  • Debt level significantly above equity

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Competitive product portfolio and market reach
  • Sustainable operating margins
  • Potential for valuation normalization over time

Key Metrics & Analysis

Financial Health

Revenue Growth22.70%
Profit Margin18.65%
P/E Ratio61.0
ROE15.88%
ROA5.30%
Debt/Equity89.00
P/B Ratio8.6
Op. Cash FlowNT$32.5B
Free Cash FlowNT$21.5B
Industry P/E40.6

Technical Analysis

TrendBullish
RSI85.7
SupportNT$314.00
ResistanceNT$727.00
MA 20NT$467.45
MA 50NT$357.21
MA 200NT$248.30
MACDBullish
VolumeIncreasing
Fear & Greed Index91.27

Valuation

Fair ValueNT$318.92
Target PriceNT$437.25
Upside/Downside-37.62%
GradeOvervalued
TypeGrowth
Dividend Yield0.76%

Risk Assessment

Beta1.22
Volatility76.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.